These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 32849529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.
    Shin C, Ito Y, Ichikawa S, Tokunaga M, Sakata-Sogawa K, Tanaka T.
    Sci Rep; 2017 Apr 05; 7():46097. PubMed ID: 28378844
    [Abstract] [Full Text] [Related]

  • 3. HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.
    Tanaka T, Shibazaki A, Ono R, Kaisho T.
    Sci Signal; 2014 Dec 16; 7(356):ra119. PubMed ID: 25515536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation.
    Lu J, Zhang J, Jiang H, Hu Z, Zhang Y, He L, Yang J, Xie Y, Wu D, Li H, Zeng K, Tan P, Xiao Q, Song Z, Pan C, Bai X, Yu X.
    Elife; 2024 Sep 13; 12():. PubMed ID: 39269442
    [Abstract] [Full Text] [Related]

  • 10. PDLIM2 is a novel E5 ubiquitin ligase enhancer that stabilizes ROC1 and recruits the ROC1-SCF ubiquitin ligase to ubiquitinate and degrade NF-κB RelA.
    Sun F, Xiao G, Qu Z.
    Cell Biosci; 2024 Jul 30; 14(1):99. PubMed ID: 39080804
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Klotho ameliorates cyclosporine A-induced nephropathy via PDLIM2/NF-kB p65 signaling pathway.
    Jin M, Lv P, Chen G, Wang P, Zuo Z, Ren L, Bi J, Yang CW, Mei X, Han D.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):451-457. PubMed ID: 28315683
    [Abstract] [Full Text] [Related]

  • 16. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.
    Guo H, Mi Z, Bowles DE, Bhattacharya SD, Kuo PC.
    J Biol Chem; 2010 Nov 26; 285(48):37787-96. PubMed ID: 20889505
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A, Kido K, Takahashi H, Takahashi C, Yanagihara Y, Saeki N, Yoshida S, Maekawa M, Honda M, Kai T, Shimizu K, Higashiyama S, Imai Y, Tokunaga F, Sawasaki T.
    J Biol Chem; 2019 Sep 20; 294(38):14135-14148. PubMed ID: 31366726
    [Abstract] [Full Text] [Related]

  • 19. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
    Shi H, Ji Y, Li W, Zhong Y, Ming Z.
    Mol Cell Probes; 2020 Oct 20; 53():101628. PubMed ID: 32621848
    [Abstract] [Full Text] [Related]

  • 20. ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway.
    Ji Y, Ni C, Shen Y, Xu Z, Tang L, Yu F, Zhu L, Lu H, Zhang C, Yang S, Wang X.
    Mol Cancer; 2024 Jul 11; 23(1):143. PubMed ID: 38992675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.